Heart Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Heart Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 1 (2005), Issue 6 (June)

1. Traumatic stress symptoms in adolescent organ transplant recipients.
   Pediatrics, 115(6): 1640-4. [Abstract] [Full-text]
2. Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study.
   Eur Respir J, 25(6): 964-9. [Abstract] [Full-text]
3. Diastolic coronary artery compression in a cardiac transplant recipient: treatment with a stent.
   Catheter Cardiovasc Interv, 65(2): 271-5. [Abstract] [Full-text]
4. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation.
   Blood, 105(12): 4871-7. [Abstract] [Full-text]
5. Coronary stenosis detection by 16-slice computed tomography in heart transplant patients: comparison with conventional angiography and impact on clinical management.
   J Am Coll Cardiol, 45(11): 1826-31. [Abstract] [Full-text]
6. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome.
   Hum Immunol, 66(5): 513-8. [Abstract] [Full-text]
7. Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure.
   Am J Cardiol, 95(12): 1492-5. [Abstract] [Full-text]
8. West Nile virus infection after cardiac transplantation.
   J Heart Lung Transplant, 24(6): 774-6. [Abstract] [Full-text]
9. Experience of percutaneous coronary intervention in the management of pediatric cardiac allograft vasculopathy.
   J Heart Lung Transplant, 24(6): 769-73. [Abstract] [Full-text]
10. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation.
    J Heart Lung Transplant, 24(6): 737-44. [Abstract] [Full-text]
11. Formation of 4-hydroxy-2-nonenal protein adducts in the ischemic rat heart after transplantation.
    J Heart Lung Transplant, 24(6): 730-6. [Abstract] [Full-text]
12. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    J Heart Lung Transplant, 24(6): 708-13. [Abstract] [Full-text]
13. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    J Heart Lung Transplant, 24(6): 703-7. [Abstract] [Full-text]
14. Osteoporosis in adult survivors of adolescent cardiac transplantation may be related to hyperparathyroidism, mild renal insufficiency, and increased bone turnover.
    J Heart Lung Transplant, 24(6): 696-702. [Abstract] [Full-text]
15. Projected survival benefit as criterion for listing and organ allocation in heart transplantation.
    J Heart Lung Transplant, 24(6): 680-9. [Abstract] [Full-text]
16. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study.
    J Heart Lung Transplant, 24(6): 645-51. [Abstract] [Full-text]
17. A history of orthotopic heart transplantation.
    Cardiol Rev, 13(4): 190-6. [Abstract] [Full-text]
18. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
    J Cutan Pathol, 32(6): 445-8. [Abstract] [Full-text]
19. CTLA4-Fas ligand gene transfer mediated by adenovirus induce long-time survival of murine cardiac allografts.
    Transplant Proc, 37(5): 2379-81. [Abstract] [Full-text]
20. Transforming growth factor beta1-modified donor cell transfusion induced allo-heart tolerance.
    Transplant Proc, 37(5): 2360-4. [Abstract] [Full-text]
21. Successful heart transplantation after 13 hours of donor heart ischemia with the use of HTK solution: a case report.
    Transplant Proc, 37(5): 2253-4. [Abstract] [Full-text]
22. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature.
    Transplant Proc, 37(5): 2250-2. [Abstract] [Full-text]
23. Donor CCR5 Delta32 polymorphism and outcome following cardiac transplantation.
    Transplant Proc, 37(5): 2247-9. [Abstract] [Full-text]
24. Impact of cardiac transplantation in 24 hours circadian blood pressure and heart rate profile.
    Transplant Proc, 37(5): 2244-6. [Abstract] [Full-text]
25. Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.
    Transplant Proc, 37(5): 2240-3. [Abstract] [Full-text]
26. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Transplant Proc, 37(5): 2231-9. [Abstract] [Full-text]
27. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.
    J Pharmacol Exp Ther, 314(1): 53-60. [Abstract] [Full-text]
28. Outcome of hearts with cold ischemic time greater than 300 minutes. A case-matched study.
    Eur J Cardiothorac Surg, 28(1): 143-8. [Abstract] [Full-text]
29. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation.
    Transpl Infect Dis, 7(1): 38-40. [Abstract] [Full-text]
30. Daclizumab to prevent rejection after cardiac transplantation.
    N Engl J Med, 352(26): 2705-13. [Abstract] [Full-text]

© 2005-2008 Heart Transplant Research Today. All Rights Reserved.